How Psychedelics Work in Your Body: A Hidden Map of Absorption, Dose, and Mystery

Bottom line: The way your body processes psychedelics is more complicated than you think — and it’s shaping the future of psychedelic medicine.

Somewhere in the quiet hours of the night, a person might take a pill, sip a tea, or inhale a vapor, convinced that the substance is rewiring their mind. But what if the real magic isn’t in the molecule, but in how the body moves it through blood, brain, and time? A new review of 32 studies reveals that the way your body absorbs, distributes, and eliminates psychedelics like LSD, psilocybin, and DMT is anything but uniform — and the differences could explain why some people feel the effects faster, deeper, or longer than others.

The Body’s Psychedelic Roadmap: What the Science Shows

When you take a psychedelic, the journey begins in your gut. But the path isn’t the same for every compound. A systematic review of 32 studies, published in 2026, found that the pharmacokinetics — the way your body processes these substances — varies dramatically. For example, LSD and psilocybin show dose-proportional peak concentrations, meaning that doubling the dose roughly doubles the effect. But DMT, the compound found in ayahuasca and some traditional Amazonian brews, behaves differently. Oral DMT is poorly absorbed, which explains why it often requires a “sacred plant” like ayahuasca (which contains MAO inhibitors) to cross into the brain. IV DMT, on the other hand, reaches the brain almost immediately, creating an intense, short-lived experience.

This distinction isn’t just a scientific curiosity. It has real implications for how these substances are used in therapy and research. For instance, the review notes that IV psilocybin may produce more rapid and intense effects than oral doses, which could be useful in clinical settings where time is a factor. But it also means that the same dose of a substance can lead to vastly different experiences — a fact that researchers are only beginning to unravel.

The Dose-Response Puzzle: Why More Isn’t Always Better

One of the most surprising findings in the review is how dose-response relationships vary between compounds. For LSD, the relationship is fairly linear: doubling the dose roughly doubles the peak concentration in the blood. This makes sense, as the body processes LSD predictably. But for DMT, the story is more complex. The review notes that oral DMT is largely inactive due to poor absorption, while IV DMT produces a much stronger and faster response. This suggests that the route of administration is as important as the dose, and that the same compound can behave differently depending on how it gets into the body.

This variation is especially important for therapeutic applications. For example, in a 2023 study on psilocybin for depression, researchers found that a single high-dose session could lead to significant and lasting improvements in mood. But the same study also noted that the effects were highly dependent on the method of administration — oral vs. IV — and that individual differences in metabolism played a role. This means that what works for one person may not work for another, and that the science of dosing is still in its early stages.

The Role of the Gut and the Blood-Brain Barrier

One of the most fascinating discoveries from the review is how the gut plays a role in psychedelic metabolism. Unlike many drugs, psychedelics don’t all cross the blood-brain barrier easily. For example, DMT is largely inactive when taken orally because it’s broken down by enzymes in the digestive tract before it can reach the brain. But when combined with an MAO inhibitor (like in ayahuasca), DMT can cross the barrier and produce its powerful effects. This suggests that the gut is not just a passive organ — it’s a key player in determining how psychedelics affect the brain.

This idea is supported by another study, which found that the gut microbiome may influence how the body processes psychedelics. The review notes that variations in gut bacteria could affect the metabolism of compounds like psilocybin and DMT, potentially altering the intensity and duration of the experience. This line of research is still in its infancy, but it hints at a deeper connection between the gut, the brain, and the psychedelic experience — one that could revolutionize our understanding of how these substances work.

Frequently Asked Questions: Demystifying the Science

Q: Is IV DMT stronger than oral DMT?
A: Yes. IV DMT bypasses the digestive system and reaches the brain almost immediately, producing a much more intense and rapid experience. Oral DMT, on the other hand, is largely inactive due to poor absorption.

Q: Why do some people feel the effects of LSD faster than others?
A: This can depend on a variety of factors, including metabolism, body weight, and the route of administration. IV LSD reaches the brain faster than oral LSD, and individual differences in how the body processes the compound can also play a role.

Q: Can the gut affect how psychedelics work?
A: Yes. The gut microbiome may influence how the body metabolizes compounds like psilocybin and DMT. This suggests that the gut is not just a passive organ but an active participant in the psychedelic experience.

Q: Are there risks associated with long-term use of psychedelics?
A: While some studies suggest that psychedelics may have therapeutic benefits, the long-term effects of repeated use are still not well understood. Most research has focused on short-term outcomes, and more studies are needed to fully assess the risks and benefits.

Q: How do the effects of psilocybin compare to LSD?
A: Both compounds are serotonergic and can produce intense psychological effects, but they differ in their pharmacokinetics. Psilocybin is more reliably absorbed orally, while LSD is more dose-proportional and has a longer duration of action.

Sources

• ¶A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjects.
• ¶The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials.

Educational Disclaimer

This article is for informational and educational purposes only. It is not medical advice, mental health advice, diagnosis, treatment guidance, or a recommendation to use any substance, supplement, therapy, or protocol.

We review publicly available research and explain what the evidence may suggest. Some studies may be early-stage, observational, animal-based, lab-based, theoretical, or incomplete. Always consult a qualified professional before making health-related decisions.

If you or someone you know is struggling, you are not alone. In the US, call or text 988 (Suicide & Crisis Lifeline). Elsewhere, contact your local emergency or crisis service.

Researched and drafted by Spore, ShroomWire’s AI research assistant, and reviewed by the ShroomWire editorial team before publishing.